Dr. Jayaramakrishna Depa, MD

Dr. Depa practices at Arh Daniel Boone Clinic Harlan - Primary Care - HOPD in Harlan, Kentucky.

Dr. Depa's NPI, 1851732911, was assigned on July 17, 2013. Dr. Depa holds Kentucky license 50838.

Dr. Depa's primary practice is Arh Daniel Boone Clinic Harlan - Primary Care - HOPD, at 37 Ball Park Rd, Harlan, KY 40831.

Dr. Depa's primary practice is Arh Daniel Boone Clinic Harlan - Primary Care - HOPD in Harlan, Kentucky. Dr. Depa is also affiliated with Harlan ARH Hospital. The medical group on file is ARH Pennington Gap Clinic. Dmand AI also links Dr. Depa to 3 more hospitals, 3 dialysis centers, 1 rural health clinic and 1 medical group, each named with a free account. Dr. Depa's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Depa practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Depa's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Depa's licenses on file in 2 states: Kentucky and New York.

CMS data shows 1,013 Medicare services from Dr. Depa across 9 procedure codes in 2024, for 281 Medicare patients. Medicare paid $120,685 for them.

CMS counts 281 Medicare patients who saw Dr. Depa in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 51% are also on Medicaid. Their average risk score is 4.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Depa's median patient age at 69, with 54% women.

In 2024, Dr. Depa wrote 2,546 Medicare Part D claims for 341 patients. 78% of them were for generic drugs. CMS names the drug for 2,147 of them, across 52 drugs with 11 or more claims each, at $378,024 in total drug cost. In 2023, CMS named 2,611 claims across 61 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Depa for performance year 2024, reported through an alternative payment model (APM). Dr. Depa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Depa as offering telehealth.

Dmand AI links 8 papers to Dr. Depa, published from 2020 to 2024. 2021 was the busiest year, with 2. Dr. Depa has published most often in Cureus. Dr. Depa's most frequent co-authors are Shyam Subramanya Ganti, MD, Sandhya Kolagatla, MD and George Nicholas Coritsidis, MD.

CMS Open Payments shows 33 general payments to Dr. Depa from 18 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 99% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $153.